Data Coordinator
START Center for Cancer Research
Data Coordinator
START Center for Cancer Research
Phase 1 cancer trials with genomic profiling
The START Center for Cancer Research (“START”) is the world’s largest early phase site network, fully dedicated to oncology clinical research. Throughout our history, START has provided hope to cancer patients in global community practices by offering "Hope Through Access” to cutting edge trials throughout the United States and Europe.
We are hiring a motivated
Data Coordinatorwho will collect, enter/transcribe, and transmit/submit clinical data for assigned investigational drug studies.
This position is offered at a pay range of$24.00 to $26.00 per hour, based on experience, qualifications, and internal equity.
Work Schedule:8:00 am-5:00 pm EST, Monday-Friday
Location: 629 Cranbury Rd., Suite 102, East Brunswick, NJ 08816
Essential Responsibilities:
Required Education & Experience:
• High School Diploma/GED.
• 2 years of clinical data entry experience.
• Knowledge and training in general office administration skills, including computer applications, filing system
Preferred Education & Experience:
• Bachelor’s degree.
• Ability to accurately perform data review and CRF completion in its entirety with minimal direction.
• Familiarity with medical terminology.
• CCRP or CCRC credentials.
Best-in-Class Benefits and Perks
We value the time, talent, and dedication our employees bring to START. Our commitment to your well-being and growth is reflected in a competitive compensation package—based on experience—along with comprehensive benefits designed to support you both personally and professionally:
More about The START Center for Cancer Research
Deeply rooted in community oncology centers globally, The START Center for Cancer Research provides access to specialized preclinical and early-phase clinical trials of novel anti-cancer agents. START clinical trial sites have conducted more than a thousand early-phase clinical trials, including for 43 therapies that were approved by the FDA. START represents the world’s largest roster of Principal Investigators (PIs) across its eight clinical trial sites. Committed to accelerating passage from trials to treatments, START delivers hope to patients, families, and physicians around the world.
Learn more at STARTresearch.com.
Ready to be part of a team changing the future of cancer treatment?
Join us in our mission to conquer cancer, one clinical trial at a time. Your expertise and dedication can help us bring hope and healing to patients worldwide. Please submit your application online.
We are an equal opportunity employer that welcomes and encourages diversity in the workplace. We do not discriminate on the basis of race, color, religion, marital status, age, national origin, ancestry, physical or mental disability, medical condition, pregnancy, genetic information, gender, sexual orientation, gender identity or expression, veteran status, or any other status protected under federal, state, or local law.
Phase 1 cancer trials with genomic profiling
START Center for Cancer Research runs Phase 1 clinical trials for novel anti-cancer therapies through a network of research sites in the United States, Spain, Portugal, and Ireland. It connects patients with early-stage trials, supported by genetic tumor profiling, multi-disciplinary care, and state-of-the-art treatment technology, to test new drugs before they reach broader use. The center distinguishes itself by its large, community-based trial network with 40+ principal investigators and a track record of conducting over 1,500 early-phase trials, including 50 therapies that later gained FDA/EMA approval. Its goal is to speed the translation of clinical research into available treatments and to expand access to innovative options for patients and physicians worldwide.
Explore more opportunities at START Center for Cancer Research